trending Market Intelligence /marketintelligence/en/news-insights/trending/w_awh1P12ctYVGshHZQ7uQ2 content esgSubNav
In This List

Ireland's Atlantic Therapeutics raises €28M to enter US market

Case Study

Powering the markets of the future with data and AI


Analyzing Sentiment in Quarterly Earnings Calls — Q3 2023

Case Study

An Alternative Investment Team Harnesses Textual Data Analytics to Find New Sources of Alpha


Battery metals - unbated long term need for supply security despite short-term headwinds

Ireland's Atlantic Therapeutics raises €28M to enter US market

Ireland's Atlantic Therapeutics Ltd. said Jan. 7 that it raised €28 million to help it enter the U.S. and other markets.

The series B funding round, led by Life Sciences Partners BV through LSP Health Economics Fund 2, will also enable Atlantic Therapeutics to launch new products and seek new clinical applications.

Andera Partners, through BioDiscovery 5 FPCI, and Atlantic Bridge Ventures, through its China-Ireland Growth Technology Fund, joined the financing.

Existing investors Seroba Life Sciences Ltd., which is also based in Ireland, and Berlin's Earlybird Venture Capital GmbH & Co. KG, further invested in Atlantic Therapeutics.

Privately held Atlantic Therapeutics markets Innovo, a medical device recently approved by the U.S. Food and Drug Administration to treat incontinence.